The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population

American Journal of Obstetrics and Gynecology

Volumn 161, Issue 2, 1989, Pages 369-373

  Lockwood, C J ^a   Romero, R ^a   Feinberg, R F ^a   Clyne, L P ^a   Coster, B ^a   Hobbins, J C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

activated partial thromboplastin time; anticardiolipin antibodies; Lupus anticoagulant

Indexed keywords

CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT;

FEMALE; HUMAN; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PREGNANCY; PRIORITY JOURNAL;

ADULT; AUTOANTIBODIES; BLOOD COAGULATION FACTORS; CARDIOLIPINS; COMPARATIVE STUDY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; PARTIAL THROMBOPLASTIN TIME; PHOSPHOLIPIDS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RISK FACTORS;

EID: 0024393524     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9378(89)90522-X     Document Type: Article

References (16)

1. Lupus anticoagulants
2. Lupus anticoagulant, recurrent abortion and prostacyclin production by cultured smooth muscle cells
3. Arterial thrombosis, intrauterine death and “lupus” anticoagulant: detection of immunoglobulin interfering with prostacyclin formation
4. Inhibition of protein C activation by endothelial cells in the presence or lupus anticoagulant [Letter]
5. Low functional and high antigenic antithrombin III level in a patient with lupus anticoagulant and recurrent thrombosis
6. Prekallikrein inhibition associated with the lupus anticoagulant
7. Lupus anticoagulant and pregnancy
8. Antibodies to phospholipids and nuclear antigens in patients with repeated abortions
9. Anticardiolipin antibodies and complement in ninety-nine women with habitual abortion
10. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant
11. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus
12. Detection of lupus anticoagulants in stored serum
13. Report of the Working Party on Acquired Inhibitors of Coagulation: studies of the “lupus” anticoagulant
14. The frequency of lupus anticoagulant in systemic lupus erythematosus
15. Anticardiolipin antibodies and lupus anticoagulant
16. Thrombosis, recurrent fetal loss, and thrombocytopenia